Independent pharmacies adapt to specialty drugs, biosimilars, cold-chain, and REMS demands.
|Articles|October 11, 2012
Independents in Texas want patients to vote Nov. 6
A group of 45 pharmacies in southern Texas are doing their best to get their patients registered, and ready to vote Nov. 6 in the hopes that the state will pay more attention to the struggling pharmacies in the four-county area.
Advertisement
Advertisement
Related to this article
During American Pharmacists Month, pharmacy teams reflect on their roles and explore ways to enhance patient care.
Lara Zakaria, PharmD, MS, CNS, FMCP, discusses her perspectives regarding the emergence of wearable technology among community pharmacy patients.
Diabetes medication experts focus on practical access and pharmacist counseling considerations for adults on obesity medication.
The oral tablet formulation was approved for adults with weakened immune systems who have not responded to other therapy.
Melissa McGivney, PharmD, FAPhA, FCCP, helps celebrate American Pharmacists Month and the innovation driving the profession forward amongst US communities.
Teva Pharmaceuticals’ new olanzapine option is the first once-monthly subcutaneous injectable on the market for schizophrenia.
The novel tool can be used to inform vaccine policy, monitor impact, and essentially strengthen overall surveillance.
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Approves New Drug for HSV Lesions in Adults
2
Pharmacists Improve Access, Safe Use of Obesity Medications
3
American Pharmacists Month: Community Pharmacies Becoming Care Providers
4
FDA Approves Once-Monthly Olanzapine Injection for Adults with Schizophrenia
5